TOMORROW: pediaTric use Of Macitentan tO delay disease pRogRessiOn in PAH Worldwide A multicenter, open-label, randomized, event-driven study to assess efficacy, safety and pharmacokinetics of macitentan
Clinical Trial Grant
Administered By
Pediatrics, Cardiology
Awarded By
Actelion Pharmaceuticals Ltd.
Start Date
August 17, 2017
End Date
June 30, 2024
Administered By
Pediatrics, Cardiology
Awarded By
Actelion Pharmaceuticals Ltd.
Start Date
August 17, 2017
End Date
June 30, 2024